Andere talen Turnstone Biologics Corp.

Aandelen

TSBX

US90042W1009

Vertraagde tijd Nasdaq Andere beurzen 19:39:23 24-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,6 ^USD	+0,78%		-2,26%	+2,16%

13/05	Turnstone Biologics Corp. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
16/04	Turnstone Biologics Corp. Kondigt wijzigingen in de Raad van Bestuur aan	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Turnstone Biologics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights	13/05
Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference	08/05
Turnstone Biologics Appoints William Waddill to its Board of Directors	16/04
Turnstone Biologics Corp. Announces Board Changes	16/04
Turnstone Biologics Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	21/03
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights	21/03
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights	21/03
Turnstone Biologics to Participate in Upcoming Investor Conferences	21/02
Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.	20/02
Turnstone Biologics Corp. Announces Demise of P. Joseph Campisi, Jr., Esq, Chief Legal Officer	20/02
Certain Common Stock of Turnstone Biologics Corp. are subject to a Lock-Up Agreement Ending on 17-JAN-2024.	17/01
Certain Stock Options of Turnstone Biologics Corp. are subject to a Lock-Up Agreement Ending on 17-JAN-2024.	17/01
Turnstone Biologics Falls 11% in Premarket Activity Tuesday After Surging 42% in Previous Regular Trading Session	05/12
Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference	27/11
Turnstone Biologics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights	10/11
Top Premarket Gainers	03/11
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting	03/11
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting	03/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Turnstone Biologics Corp.

Aandelen

TSBX

US90042W1009

Andere talen

Filters